JPWO2021182574A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021182574A5
JPWO2021182574A5 JP2021532007A JP2021532007A JPWO2021182574A5 JP WO2021182574 A5 JPWO2021182574 A5 JP WO2021182574A5 JP 2021532007 A JP2021532007 A JP 2021532007A JP 2021532007 A JP2021532007 A JP 2021532007A JP WO2021182574 A5 JPWO2021182574 A5 JP WO2021182574A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
chain variable
variable region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021532007A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021182574A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/009799 external-priority patent/WO2021182574A1/ja
Publication of JPWO2021182574A1 publication Critical patent/JPWO2021182574A1/ja
Publication of JPWO2021182574A5 publication Critical patent/JPWO2021182574A5/ja
Priority to JP2025156924A priority Critical patent/JP2025181951A/ja
Pending legal-status Critical Current

Links

JP2021532007A 2020-03-12 2021-03-11 Pending JPWO2021182574A1 (https=)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025156924A JP2025181951A (ja) 2020-03-12 2025-09-22 癌の治療及び/又は予防のための医薬品

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020043022 2020-03-12
PCT/JP2021/009799 WO2021182574A1 (ja) 2020-03-12 2021-03-11 癌の治療及び/又は予防のための医薬品

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025156924A Division JP2025181951A (ja) 2020-03-12 2025-09-22 癌の治療及び/又は予防のための医薬品

Publications (2)

Publication Number Publication Date
JPWO2021182574A1 JPWO2021182574A1 (https=) 2021-09-16
JPWO2021182574A5 true JPWO2021182574A5 (https=) 2024-02-28

Family

ID=77670660

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021532007A Pending JPWO2021182574A1 (https=) 2020-03-12 2021-03-11
JP2025156924A Pending JP2025181951A (ja) 2020-03-12 2025-09-22 癌の治療及び/又は予防のための医薬品

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025156924A Pending JP2025181951A (ja) 2020-03-12 2025-09-22 癌の治療及び/又は予防のための医薬品

Country Status (7)

Country Link
US (1) US20230159635A1 (https=)
EP (1) EP4119160A4 (https=)
JP (2) JPWO2021182574A1 (https=)
KR (1) KR20220151684A (https=)
BR (1) BR112022018161A2 (https=)
CA (1) CA3175279A1 (https=)
WO (1) WO2021182574A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101638490B1 (ko) * 2008-08-05 2016-07-11 도레이 카부시키가이샤 암의 치료 및 예방용 의약 조성물
CN118852442A (zh) * 2023-04-26 2024-10-29 上海麦科思生物医药有限公司 抗ptk7抗体及其用途

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
CA2194907A1 (en) 1994-07-13 1996-02-01 Kouji Matsushima Reshaped human antibody against human interleukin-8
US6677436B1 (en) 1998-04-03 2004-01-13 Chugai Seiyaku Kabushiki Kaisha Humanized antibody against human tissue factor (TF) and process of production of the humanized antibody
ES2434961T5 (es) 1998-04-20 2018-01-18 Roche Glycart Ag Ingeniería de glicosilación de anticuerpos para mejorar la citotoxicidad celular dependiente del anticuerpo
US6737056B1 (en) 1999-01-15 2004-05-18 Genentech, Inc. Polypeptide variants with altered effector function
EP1176195B1 (en) 1999-04-09 2013-05-22 Kyowa Hakko Kirin Co., Ltd. Method for controlling the activity of immunologically functional molecule
FR2807767B1 (fr) 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
JP2006524039A (ja) 2003-01-09 2006-10-26 マクロジェニクス,インコーポレーテッド 変異型Fc領域を含む抗体の同定および作製ならびにその利用法
US8388955B2 (en) 2003-03-03 2013-03-05 Xencor, Inc. Fc variants
DE10359795A1 (de) 2003-12-19 2005-07-21 Bayer Technology Services Gmbh Strangverdampfervorrichtung
CN102007800B (zh) * 2008-04-18 2014-12-10 艾利森电话股份有限公司 多接入网络环境中的接入网络选择
KR101638490B1 (ko) * 2008-08-05 2016-07-11 도레이 카부시키가이샤 암의 치료 및 예방용 의약 조성물
AU2010270979B2 (en) 2009-06-22 2015-04-23 Medimmune, Llc Engineered Fc regions for site-specific conjugation
SG178925A1 (en) 2009-09-22 2012-04-27 Volker Sandig Process for producing molecules containing specialized glycan structures
KR101842893B1 (ko) 2010-02-04 2018-03-28 도레이 카부시키가이샤 암의 치료 및/또는 예방용 의약 조성물
BR112012018943A8 (pt) 2010-02-04 2017-12-19 Toray Industries medicamento e método para o tratamento e/ou prevenção de um câncer
MX340015B (es) 2010-02-04 2016-06-22 Toray Industries Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
RU2598258C2 (ru) 2010-02-04 2016-09-20 Торэй Индастриз, Инк. Фармацевтическая композиция для лечения и/или профилактики рака
MX342291B (es) 2010-02-04 2016-09-23 Toray Industries Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
HUE025678T2 (en) * 2010-02-04 2016-04-28 Toray Industries A pharmaceutical composition for the treatment and / or prevention of cancer
BR112012024489A2 (pt) 2010-03-29 2016-05-31 Zymeworks Inc anticorpos com função efetora suprimida ou aumentada
KR102041832B1 (ko) 2011-08-04 2019-11-08 도레이 카부시키가이샤 췌장암의 치료 및/또는 예방용 의약 조성물
PT2740794T (pt) 2011-08-04 2018-06-14 Toray Industries Composição farmacêutica para o tratamento e/ou profilaxia de cancro
US9181348B2 (en) 2011-08-04 2015-11-10 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prophylaxis of cancer
JP6070191B2 (ja) 2011-08-04 2017-02-01 東レ株式会社 癌の治療及び/又は予防用医薬組成物
PT2740793T (pt) 2011-08-04 2018-02-23 Toray Industries Composição de fármacos para o tratamento e/ou a prevenção de cancro
RU2595400C2 (ru) 2011-08-04 2016-08-27 Торэй Индастриз, Инк. Фармацевтическая композиция для лечения и/или профилактики злокачественной опухоли
HUE044611T2 (hu) 2012-02-21 2019-11-28 Toray Industries Gyógyászati készítmény rák kezelésére
PT2818483T (pt) 2012-02-21 2017-10-09 Toray Industries Composição medicinal para tratamento e/ou prevenção de cancro
US9260513B2 (en) * 2012-02-21 2016-02-16 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
BR112014021103A2 (pt) 2012-02-21 2019-10-15 Toray Industries, Inc Anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo
PT2832366T (pt) 2012-03-30 2018-01-25 Toray Industries Composição farmacêutica para o tratamento e/ou a prevenção de cancro de vesícula biliar
KR102155531B1 (ko) * 2012-03-30 2020-09-15 도레이 카부시키가이샤 간암의 치료 및/또는 예방용 의약 조성물
CN112587671A (zh) 2012-07-18 2021-04-02 博笛生物科技有限公司 癌症的靶向免疫治疗
US9177410B2 (en) * 2013-08-09 2015-11-03 Ayla Mandel System and method for creating avatars or animated sequences using human body features extracted from a still image
ES2704909T3 (es) 2013-08-09 2019-03-20 Toray Industries Composición farmacéutica para el tratamiento y/o la prevención del cáncer
EP3303398A1 (en) * 2015-05-29 2018-04-11 Merrimack Pharmaceuticals, Inc. Combination cancer therapies
JP7342701B2 (ja) * 2018-03-30 2023-09-12 東レ株式会社 癌の治療及び/又は予防用医薬組成物
JP2020043022A (ja) 2018-09-13 2020-03-19 オンキヨー株式会社 面状発光装置

Similar Documents

Publication Publication Date Title
AU2019242520B2 (en) Pharmaceutical composition for treatment and/or prevention of cancer
EP4582100A1 (en) Medicament for treatment and/or prevention of cancer
JPWO2021182573A5 (https=)
EP4119156A1 (en) Medicament for treatment and/or prevention of cancer
EP4360649A1 (en) Medicament for treatment and/or prevention of cancer
JPWO2021182574A5 (https=)
JPWO2021182571A5 (https=)
JPWO2021182570A5 (https=)
JP7715041B2 (ja) 癌の治療及び/又は予防のための医薬品
JP7793986B2 (ja) 癌の治療及び/又は予防のための医薬品
EP4119160A1 (en) Medicament for treatment and/or prevention of cancer
JPWO2021182572A5 (https=)
JP7793985B2 (ja) 癌の治療及び/又は予防のための医薬品
EP4360648A1 (en) Medicament for treatment and/or prevention of cancer
EP4378476A1 (en) Medicament for treatment and/or prevention of cancer
EP4578458A1 (en) Medicament for treatment and/or prevention of cancer
EP4578457A1 (en) Pharmaceutical for treating and/or preventing cancer
EP4582101A1 (en) Medicament for treatment and/or prevention of cancer
EP4640235A1 (en) Medicament for treatment and/or prevention of cancer